Cargando…
Evaluation of the serotonin pathway as a biomarker in cholangiocarcinoma
BACKGROUND: Cholangiocarcinomas (CCAs) are rare and aggressive malignant tumors of the biliary tract. Serotonin (5HT) has tumor-promoting effects in CCA while inhibition of 5HT synthesis can decrease tumor growth. METHODS: In this retrospective study, we evaluated the expression of 5HT and tryptopha...
Autores principales: | Fountzilas, Christos, Velasco, Sylvia Alarcon, Bshara, Wiam, LeVea, Charles M., Gupta, Medhavi, Ji, Wenyan, George, Anthony, Attwood, Kristopher, Iyer, Renuka V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643599/ https://www.ncbi.nlm.nih.gov/pubmed/37969829 http://dx.doi.org/10.21037/jgo-23-115 |
Ejemplares similares
-
A multicentre phase 1b/2 study of tivozanib in patients with advanced inoperable hepatocellular carcinoma
por: Fountzilas, Christos, et al.
Publicado: (2020) -
Poly(ADP-Ribose) Polymerase Inhibitors in Pancreatic Cancer: A New Treatment Paradigms and Future Implications
por: Gupta, Medhavi, et al.
Publicado: (2019) -
Oral Floor and Gingival Metastasis of Cholangiocarcinoma: A Case Report and Review of the Literature
por: Nakanishi, Yukihiro, et al.
Publicado: (2014) -
Clinicopathological characteristics and outcomes of rare histologic subtypes of gallbladder cancer over two decades: A population-based study
por: Samuel, Sandeep, et al.
Publicado: (2018) -
CD24 Expression is an Independent Prognostic Marker in Cholangiocarcinoma
por: Agrawal, Shefali, et al.
Publicado: (2007)